Further experiments revealed the knockdown of FEZF1-AS1 reduced FEZF1 mRNA and protein expression in CRC cells, and that the expression levels of FEZF1 were significantly higher in tumor tissues. The gene discussed is FEZF1; the disease is neoplasm.